Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
National Skin Cancer Centres, South Brisbane, Queensland, Australia.
Australas J Dermatol. 2023 May;64(2):177-193. doi: 10.1111/ajd.14023. Epub 2023 Mar 24.
Skin cancer is a growing global problem and a significant health and economic burden. Despite the practical necessity for skin cancer to be managed in primary care settings, little is known about how quality of care is or should be measured in this setting. This scoping review aimed to capture the breadth and range of contemporary evidence related to the measurement of quality in skin cancer management in primary care settings. Six databases were searched for relevant texts reporting on quality measurement in primary care skin cancer management. Data from 46 texts published since 2011 were extracted, and quality measures were catalogued according to the three domains of the Donabedian model of healthcare quality (structure, process and outcome). Quality measures within each domain were inductively analysed into 13 key emergent groups. These represented what were deemed to be the most relevant components of skin cancer management as related to structure, process or outcomes measurement. Four groups related to the structural elements of care provision (e.g. diagnostic tools and equipment), five related to the process of care delivery (e.g. diagnostic processes) and four related to the outcomes of care (e.g. poor treatment outcomes). A broad range of quality measures have been documented, based predominantly on articles using retrospective cohort designs; systematic reviews and randomised controlled trials were limited.
皮肤癌是一个全球性的日益严重的问题,也是一个重大的健康和经济负担。尽管在初级保健环境中管理皮肤癌具有实际必要性,但对于如何衡量这种环境中的护理质量却知之甚少。本范围界定审查旨在了解与初级保健皮肤癌管理质量衡量相关的当代证据的广度和范围。六个数据库被搜索以获取报告初级保健皮肤癌管理质量衡量的相关文本。从 2011 年以来发表的 46 篇文章中提取数据,并根据医疗保健质量的 Donabedian 模型(结构、过程和结果)的三个领域对质量措施进行分类。对每个领域内的质量措施进行归纳分析,得出 13 个主要的新兴群组。这些被认为是与结构、过程或结果测量相关的皮肤癌管理的最相关组成部分。四个组与护理提供的结构要素有关(例如诊断工具和设备),五个组与护理提供的过程有关(例如诊断过程),四个组与护理的结果有关(例如治疗效果不佳)。记录了广泛的质量措施,主要基于使用回顾性队列设计的文章;系统评价和随机对照试验有限。